After the vaccine of two companies in the war against the Coronavirus has been approved for emergency use, it may be difficult for the vaccine companies standing in front lines to be tested. There may be a problem with getting volunteers for their vaccines. It is known that on January 3 of this year, DCGI approved the Oxford Vaccine and indigenous Covaxin made at Serum Institute. Companies say recruitment has been adversely affected due to the news of the early availability of the vaccine.
Dr. V Krishna Mohan of Bharat Biotech said in a webinar, "There are several press releases without getting approval for emergency use, saying that their vaccine will be available soon." This is going to cause a lot of difficulty in recruitment, because most people are thinking about whether they should take part in clinical trials or not. After all, the vaccine is going to come soon. " Trials are taking place at the same time when the work of approving vaccines for emergency use is also going on in the country.
'Big challenge for India biotech'
He said that the challenge for Bharat Biotech was huge, as they were focusing on the older age group. He said that the oldest person to enroll for the covariate trial was 97. Mohan said, "Hospitals have also asked us whether it is morally right to continue clinical trials even when you have received emergency use. These questions should be answered. "Let us know that at least six human trials of corona vaccines are going on in the country. This is Zydus Cadila, which has recently started a third phase trial. Russia has Sputnik 5, whose second and third phase trials are being conducted by Dr. Reddy.
There is also an ongoing trial of these vaccines
Serum Institute of India also has the second vaccine Novavax, which is undergoing Phase II trials. Biological E and Genova are testing the first phase of their vaccine. Apart from this, work is also underway on another biotech vaccine of Bharat Biotech. Cadila Healthcare Chairperson Dr. Pankaj Patel also believes that recruitment time is going to be very challenging. He says the challenge will be to meet recruitment speed and volunteers. At the same time, there is also a concern that after the introduction of the vaccine, the weak people will get vaccinated soon.
Ayushmann Khurrana is one of the finest actors in Hindi cinema. In the world of cinema, he is kno
Tomorrow South's much-awaited film RRR is releasing. Since Bahubali, many South films have been
Bholaa Box Office Collection Day 6: Ajay Devgn's Bholaa finally gets a chance to celebrate. Bhola
Rain has caused havoc in the Northeast. People in many states have been badly affected by the rai
Team India made a great start to their campaign in the Asia Cup by defeating Pakistan by 5 wicket
Leader of Opposition in West Bengal Assembly Shubhendu Adhikari has demanded that next year's Ben
Karnataka 1st PUC Result 2023: Karnataka 1st PUC result released, download like this
Karnataka 1st PUC Result 2023 released: The Department of Pre-University Education has released t
After Corona, now American citizens are troubled by inflation. This is the reason why one in ever
The US has said that DNA tests will not be conducted on the body of slain al-Qaeda leader Ayman a
The Women's Commission had summoned Ranveer Allahabadia, Samay Raina, and Apoorva Makhija, along
